Prof Shimon Slavin is an Israeli scientist, a professor of medicine, and an expert in cancer immunotherapy and cell therapy. He is the Founder, Medical and Scientific Director of Biotherapy International.

Prof Slavin is the author of four books and over 680 scientific articles. His current research activities are aimed at developing new methods of immunotherapy to treat multidrug-resistant cancers. The professor continues to practice clinical medicine, admitting and consulting remotely with patients from all over the world.

Biotherapy International is an international centre for cancer immunotherapy and cellular therapy, specialised in innovative treatments for patients who have limited or exhausted conventional treatment options.

Biotherapy has a partner clinic in Germany, situated in Rheinfelden, near the Swiss border. The clinic specialises in cutting-edge therapies, including advanced cancer immunotherapy and stem cell treatments for non-malignant conditions. Germany permits experimental treatments that have yet to be established as standard protocols for oncological diseases. These therapies are available under compassionate use provisions.

Сancer immunotherapy
Regenerative Medicine

Cancer immunotherapy methods utilised in the Germany branch are;
Cancer vaccines
Oncolytic viruses
ATACK Allogeneic Targeted Activated Cancer Killer cells
COMBAT Combined anti-tumour therapy